A potential, although modest, increase in the risk of a rare eye condition sometimes called "eye stroke" was found in patients with Type 2 diabetes who use semaglutide, also used...
| |
| | | |   | | Dear Reader, | You can count on The Epoch Times. Our reporters are working around the clock to deliver prompt, factual, and insightful reporting. Proudly reader-funded, we are free from the influence of any government, corporation, or political party.
Seize our Presidents' Day offer (75 percent off) to lock in one full year subscription: $1 a week for an entire year. | | SUBSCRIBE NOW >> | | Cancel anytime. | | | | | LIFESTYLE | | | | | | | | | | | | EPOCH BUY | | | | | | ART & CULTURE | | | | | | AMERICAN ESSENCE | | | | EPOCH FUN | | | | | |
| | | FOLLOW US     | | The health information in this newsletter is not intended to replace a one-on-one relationship with a qualified healthcare professional and is not intended as medical advice, diagnosis, or treatment. It is intended as a sharing of knowledge and information from the research and experience of many experts and journalists. The Epoch Times encourages you to make your own healthcare decisions based upon your research and in partnership with a qualified healthcare professional.
*When sharing an article, giftaccess@TheEpochTimes.com is added to the list of recipients. If your friend is not already a subscriber, we will send them a special link for free access to the article.
Manage your email preferences here or unsubscribe from Bright here. Copyright © 2025 The Epoch Times, All rights reserved. Our mailing address is: The Epoch Times, 229 W 28th St, Fl.5, New York, NY 10001 | Contact Us | | |
No comments:
Post a Comment